Industries > Pharma > Pharma Leader Series: Top Generic Drug Producers Market Forecast 2019-2029

Pharma Leader Series: Top Generic Drug Producers Market Forecast 2019-2029

North America, Europe, India, Rest of the World (RoW)

PUBLISHED: 29 January 2019
PAGES: 207
PRODUCT CODE: PHA0352
SUBMARKET: Therapeutic Drugs

Clear
WOOCS 2.2.1

The top 10 generic drug producers have 61% share of the total revenue made by these top 50 companies. 22% of the top 50 generic drug producers are in North America. 30% of the top 50 generic drug producers fall under the RoW region. This figure reflects the increasing penetration of generics on a global scale with many pharmaceutical companies realising this industry as a primary source of revenue.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 207-page report you will receive 74 tables and 72 figures– all unavailable elsewhere.

The 207-page report provides clear detailed insight into the top 50 generic drug producers. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand-new report today you stay better informed and ready to act.

Report Scope

• This report ranks the world’s top 50 generic drug manufacturers according to their generic drug revenues in 2017.

• Our report assesses the leading generic drug manufacturers worldwide. In general a company profile gives you the following information:
• Discussion of activities, technologies and recent financial results
• Assessment of developments – mergers and acquisitions (M&A), new products, outlooks, challenges and plans
• Historical revenue ($) and CAGR (%) of top players
• Forecasting of generic drug revenues to 2029 (for 18 leading companies).

• This report discusses the factors that affect the industry:
• M&A activity and related partnerships
• Global and regional strategies – extending business reach
• Competition from companies based in emerging national markets
• Increasing specialisation by leading players, including big pharma companies
• Increasing consolidation of the generics industry
• Advances in production technologies, including difficult-to-make generics and biosimilars – important shifts and opportunities in the industry.

• This report analyses the leading generic drug manufacturers in North America, including these companies:
• Abbott
• Akorn
• Alvogen
• Endo
• Impax
• Mallinckrodt
• Mylan
• Pfizer
• Pharmascience
• Valeant

• This report analyses the leading generic drug manufacturers in Europe, including these companies:
• Fresenius Kabi
• Gedeon Richter
• Insud Pharma
• Krka
• Novartis (Sandoz)
• Perrigo
• Pharmstandard
• Polpharma
• Sanofi
• Stada Arzneimittel

Top Generic Drug Producers Market Forecast 2019-2029

• This report analyses the leading generic drug manufacturers in India, including these companies:
• Sun Pharmaceuticals
• Aurobindo
• Lupin
• Cipla
• Dr Reddy’s
• Glenmark
• Torrent Pharma
• Cadila
• Wockhardt
• Ipca

• This report analyses the leading generic drug manufacturers in RoW, including these companies:
• Teva
• EMS
• Aspen
• Sawai Pharmaceutical
• Nichi-Iko
• Abdi Ibrahim
• Towa Pharmaceutical
• Eurofarma
• Taro Pharmaceutical
• Hypermarcas

Visiongain’s study is intended for anyone requiring commercial analyses for the top generic drug manufacturers. You find data, trends and predictions.

Buy our report today Pharma Leader Series: Top Generic Drug Producers Market Forecast 2019-2029: North America, Europe, India, Rest of the World (RoW).

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Download sample pages

Complete the form below to download your free sample pages for Pharma Leader Series: Top Generic Drug Producers Market Forecast 2019-2029


Download sample pages

Complete the form below to download your free sample pages for Pharma Leader Series: Top Generic Drug Producers Market Forecast 2019-2029


Latest Pharma news

Visiongain Publishes Pharmaceutical Product Information Management System Market Report 2020-2030

Some of the major factors fuelling the growth of global market include significant advantages associated with PIM solutions and inclination towards centralized models among across pharma sector.

19 October 2020

READ

Visiongain Publishes Pulmonary/Respiratory Drug Delivery Market Report 2020-2030

The coronavirus outbreak has negatively impacted all the economies and industries across the globe. Hence, for the next 1-2 years, the global respiratory drug delivery market is expected to take a hit.

12 October 2020

READ

Visiongain Publishes Real-World Evidence (RWE) Solutions Market Report 2020-2030

We predict strong revenue growth through to 2030. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

02 October 2020

READ

Visiongain Publishes mRNA Vaccines Market Report 2021-2031

The development of mRNA vaccines is driven by new biotechnologies and nanotechnologies. Emerging delivery technologies, such as electroporation (EP), innovative vaccine formats like mRNA preventive boost, and new molecular adjuvant technologies are particularly important for mRNA vaccines reaching their potential.

02 October 2020

READ

Categories

Category